BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oura K, Morishita A, Masaki T. Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma-A Review. Int J Mol Sci 2020;21:E8362. [PMID: 33171811 DOI: 10.3390/ijms21218362] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Machida K. HCV and tumor-initiating stem-like cells. Front Physiol 2022;13:903302. [DOI: 10.3389/fphys.2022.903302] [Reference Citation Analysis]
2 Ghamar Talepoor A, Doroudchi M. Immunosenescence in atherosclerosis: A role for chronic viral infections. Front Immunol 2022;13:945016. [DOI: 10.3389/fimmu.2022.945016] [Reference Citation Analysis]
3 Li H, Yang C, Lo S. Roles of microRNAs in Hepatitis C Virus Replication and Pathogenesis. Viruses 2022;14:1776. [DOI: 10.3390/v14081776] [Reference Citation Analysis]
4 Zhang X, Chen J, Wang G, Chen H, Cao J, Xie L, Luo Y. Interactive effects of fluoride and seleno-l-methionine at environmental related concentrations on zebrafish (Danio rerio) liver via the gut-liver axis. Fish Shellfish Immunol 2022;127:690-702. [PMID: 35809884 DOI: 10.1016/j.fsi.2022.07.006] [Reference Citation Analysis]
5 Wang P, Yang X, Liu D, Yang Y, Zhang Y, Wang G. Construction of a competing endogenous RNA network to analyse glucose-6-phosphate dehydrogenase dysregulation in hepatocellular carcinoma. Biosci Rep 2022;42:BSR20220674. [PMID: 35712981 DOI: 10.1042/BSR20220674] [Reference Citation Analysis]
6 Tang Q, Zeng M, Chen L, Fu N. Targeting Thyroid Hormone/Thyroid Hormone Receptor Axis: An Attractive Therapy Strategy in Liver Diseases. Front Pharmacol 2022;13:871100. [PMID: 35721201 DOI: 10.3389/fphar.2022.871100] [Reference Citation Analysis]
7 Wen M, Xu H, Peng H, Sheng Y, Yang W, Yan J. MiR-27a-3p targets USP46 to inhibit the cell proliferation of hepatocellular carcinoma. Chem Biol Drug Des 2022. [PMID: 35637630 DOI: 10.1111/cbdd.14063] [Reference Citation Analysis]
8 Xu H, Li B. MicroRNA-582-3p targeting ribonucleotide reductase regulatory subunit M2 inhibits the tumorigenesis of hepatocellular carcinoma by regulating the Wnt/β-catenin signaling pathway. Bioengineered 2022;13:12876-87. [PMID: 35609318 DOI: 10.1080/21655979.2022.2078026] [Reference Citation Analysis]
9 Xue C, Gu X, Bao Z, Su Y, Lu J, Li L. The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment. Front Immunol 2022;13:847728. [PMID: 35281015 DOI: 10.3389/fimmu.2022.847728] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Chuffa LGDA, de Souza MC, Cruz EMS, Ferreira FB, de Morais JMB, Seiva FRF. Hepatocellular carcinoma and miRNAs: An in silico approach revealing potential therapeutic targets for polyphenols. Phytomedicine Plus 2022;2:100259. [DOI: 10.1016/j.phyplu.2022.100259] [Reference Citation Analysis]
11 Men Y, Zhai Y, Wu L, Liu L, Zhang W, Jiang W, Bi N, Song Y, Hui Z, Wang L. MiR-323a-3p acts as a tumor suppressor by suppressing FMR1 and predicts better esophageal squamous cell carcinoma outcome. Cancer Cell Int 2022;22:140. [PMID: 35351128 DOI: 10.1186/s12935-022-02541-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Hao L, Zhang M, Tao Y, Xu H, Liu Q, Yang K, Wei R, Zhou H, Jin T, Liu X, Xue Z, Shen W, Cao J, Pan Z, Tang C. miRNA-22 Upregulates Mtf1 in Dorsal Horn Neurons and Is Essential for Inflammatory Pain. Oxidative Medicine and Cellular Longevity 2022;2022:1-23. [DOI: 10.1155/2022/8622388] [Reference Citation Analysis]
13 Shi T, Iwama H, Fujita K, Kobara H, Nishiyama N, Fujihara S, Goda Y, Yoneyama H, Morishita A, Tani J, Yamada M, Nakahara M, Takuma K, Masaki T. Evaluating the Effect of Lenvatinib on Sorafenib-Resistant Hepatocellular Carcinoma Cells. Int J Mol Sci 2021;22:13071. [PMID: 34884875 DOI: 10.3390/ijms222313071] [Reference Citation Analysis]
14 Qu J, Luo M, Zhang J, Han F, Hou N, Pan R, Sun X. A paradoxical role for sestrin 2 protein in tumor suppression and tumorigenesis. Cancer Cell Int 2021;21:606. [PMID: 34784907 DOI: 10.1186/s12935-021-02317-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Xu L, Yang C, Wang J, Li Z, Huang R, Ma H, Ma J, Wang Q, Xiong X. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice. Biochem Biophys Res Commun 2021;578:142-9. [PMID: 34562654 DOI: 10.1016/j.bbrc.2021.09.036] [Reference Citation Analysis]
16 Pietropaolo V, Prezioso C, Moens U. Role of Virus-Induced Host Cell Epigenetic Changes in Cancer. Int J Mol Sci 2021;22:8346. [PMID: 34361112 DOI: 10.3390/ijms22158346] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
17 Tadokoro T, Morishita A, Masaki T. Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA. Int J Mol Sci 2021;22:8139. [PMID: 34360904 DOI: 10.3390/ijms22158139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Canale M, Foschi FG, Andreone P, Ercolani G, Marisi G, Conti F, Vukotic R, Guarneri V, Burgio V, Ratti F, Aldrighetti L, De Cobelli F, Cascinu S, Ulivi P, Casadei-Gardini A. Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery. HPB (Oxford) 2021:S1365-182X(21)00603-1. [PMID: 34366240 DOI: 10.1016/j.hpb.2021.06.421] [Reference Citation Analysis]
19 Liu W, Gao X, Chen X, Zhao N, Sun Y, Zou Y, Guan Y, Yang L, Pei X, Wang G, Wang B, Li M, Song W. miR-139-5p Loss-Mediated WTAP Activation Contributes to Hepatocellular Carcinoma Progression by Promoting the Epithelial to Mesenchymal Transition. Front Oncol 2021;11:611544. [PMID: 33937023 DOI: 10.3389/fonc.2021.611544] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
20 Loosen SH, Castoldi M, Jördens MS, Roy S, Vucur M, Kandler J, Hammerich L, Mohr R, Tacke F, Ulmer TF, Neumann UP, Luedde T, Roderburg C. Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC. PLoS One 2021;16:e0247917. [PMID: 33711036 DOI: 10.1371/journal.pone.0247917] [Reference Citation Analysis]